FACIAL DYSMORPHISM

FACIAL DYSMORPHISM was reported 221 times

These drug classes are most commonly taken by patients reporting FACIAL DYSMORPHISM:

# Drug Count
0 Mood Stabilizer [EPC] 39
1 Anti-epileptic Agent [EPC] 27
2 Benzodiazepine [EPC] 22
3 Folate Analog Metabolic Inhibitor [EPC] 12
4 Nonsteroidal Anti-inflammatory Drug [EPC] 9
5 Vitamin B12 [EPC] 9
6 Vitamin C [EPC] 9
7 Vitamin D [EPC] 9
8 Azole Antifungal [EPC] 8
9 Retinoid [EPC] 8
10 Corticosteroid [EPC] 6
11 Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6
12 Alkylating Drug [EPC] 5
13 Atypical Antipsychotic [EPC] 5
14 Nucleoside Metabolic Inhibitor [EPC] 5
15 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 3
16 Nitrofuran Antibacterial [EPC] 3
17 Prostaglandin E1 Analog [EPC] 3
18 Aminosalicylate [EPC] 2
19 Cytochrome P450 3A Inhibitor [EPC] 2
20 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 2
21 Platinum-based Drug [EPC] 2
22 Protease Inhibitor [EPC] 2
23 Purine Antimetabolite [EPC] 2
24 beta Lactamase Inhibitor [EPC] 2
25 Acetylcholine Release Inhibitor [EPC] 1
26 Angiotensin 2 Receptor Blocker [EPC] 1
27 Anthelmintic [EPC] 1
28 Histamine-2 Receptor Antagonist [EPC] 1
29 Insulin Analog [EPC] 1
30 Neuromuscular Blocker [EPC] 1
31 Nitroimidazole Antimicrobial [EPC] 1
32 Opioid Agonist [EPC] 1
33 Phenothiazine [EPC] 1
34 Progestin [EPC] 1
35 Progestin-containing Intrauterine System [EPC] 1
36 Recombinant Human Growth Hormone [EPC] 1
37 Serotonin Reuptake Inhibitor [EPC] 1
38 Serotonin-1b and Serotonin-1d Receptor Agonist [EPC] 1
39 Thiazide Diuretic [EPC] 1
40 Thyroid Hormone Synthesis Inhibitor [EPC] 1
41 beta-Adrenergic Blocker [EPC] 1